Skip to main content
logo
Evoq Remedies Limited (BOM:543500)
India flag India · Delayed Price · Currency is INR
1.750
-0.020 (-1.13%)
At close: Aug 4, 2026

Evoq Remedies Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
267.57267.57141.7163.09264.13167.83
Revenue Growth
-34.30%88.81%124.62%-76.11%57.38%67.42%
Gross Profit
12.8212.8210.8947.4370.8529.78
Operating Income
-2.51-2.511.286.1222.8614.63
Net Income
-2.4-2.40.884.5216.1910.91
Earnings Per Share
-0.10-0.100.040.331.191.09
EPS Growth
---89.27%-72.27%9.17%-84.75%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.050.052.141.231.5430.94
Total Debt
0.730.73-42.3895.7681.58
Net Cash (Debt)
-0.68-0.682.14-41.15-94.23-50.64
Net Cash Growth
------
Net Cash Per Share
-0.03-0.030.09-3.03-6.93-5.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-2.82-2.82-146.2353.2-43.46-276.38
Capital Expenditures
---2.58-0.12-0.13-
Free Cash Flow
-2.82-2.82-148.8153.08-43.59-276.38
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
4.79%4.79%7.68%75.19%26.82%17.74%
Operating Margin
-0.94%-0.94%0.91%9.69%8.65%8.72%
Pretax Margin
-0.94%-0.94%0.90%9.69%8.65%8.69%
Profit Margin
-0.90%-0.90%0.62%7.17%6.13%6.50%
FCF Margin
-1.05%-1.05%-105.01%84.13%-16.50%-164.68%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--72.2726.0610.9128.17
P/FCF Ratio
---2.22--
PS Ratio
0.160.210.451.870.671.83